EXHIBIT 10.12 [***] = CONFIDENTIAL PORTIONS OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. NON-EXCLUSIVE LICENSE AGREEMENT THIS NON-EXCLUSIVE LICENSE AGREEMENT ("Agreement")...Non-Exclusive License Agreement • September 16th, 2005 • Brillian Corp • Radio & tv broadcasting & communications equipment • New York
Non-exclusive license to use Co-registrationNon-Exclusive License Agreement • February 15th, 2024
By streaming and/or manipulating and/or using the PRODUCT, the LICENSEE signifies that it unconditionally accepts all the terms and conditions of the present license agreement (hereinafter referred to as the “LICENSE”). The acceptance by the LICENSEE of this LICENSE is the condition upon which UP42 makes the PRODUCT available to the LICENSEE. The LICENSEE of the PRODUCT shall guarantee that the PRODUCT and any copy are used in strict compliance with the terms hereof.
ContractNon-Exclusive License Agreement • September 1st, 2023
This Non-Exclusive {LICENSE_NAME} License Agreement (the "Agreement"), having been made on and effective as of {CONTRACT_DATE} (the "Effective Date") by and between
R E C I T A L S ---------------Non-Exclusive License Agreement • July 21st, 2006 • Cytodyn Inc • Pharmaceutical preparations • Massachusetts
WORLD BEER CUP COMPETITION NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • October 28th, 2022 • Colorado
This license agreement (the “Agreement”) is by and between Brewers Association, Inc., a Colorado corporation with offices located in Boulder, Colorado, USA (“Licensor”) and the Licensee, designated below in the signature block (“Licensee”), and is effective as of the Effective Date (defined below in Section 1).
Non-exclusive license to use Oil Storage Tank DetectionNon-Exclusive License Agreement • April 15th, 2023
By streaming and/or manipulating and/or using the PRODUCT, the LICENSEE signifies that it unconditionally accepts all the terms and conditions of the present licence agreement (hereinafter referred to as the “LICENCE”). The acceptance by the LICENSEE of this LICENCE is the condition upon which AIRBUS DS makes the PRODUCT available to the LICENSEE. The LICENSEE of the PRODUCT shall guarantee that the PRODUCT and any copy are used in strict compliance with the terms hereof.
In order to make your work(s) openly available on the web via Merrimack ScholarWorks, you as a contributor are asked to sign the Merrimack ScholarWorks agreement which confirms that you as the Contributor or the copyright holder (if different from the...Non-Exclusive License Agreement • December 16th, 2019
This non-exclusive license defines the terms for the deposit of materials in all formats into the digital repository of materials collected, preserved, and made available through Merrimack ScholarWorks: a service of McQuade Library.
NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN THE CITY OF MILPITAS, CALIFORNIA AND GTE MOBILNET OF CALIFORNIA LIMITED PARTNERSHIP, D/B/A VERIZON WIRELESS, FOR THE USE OF MUNICIPAL FACILITIES TO INSTALL SMALL CELL ANTENNAS AND ASSOCIATED EQUIPMENTNon-Exclusive License Agreement • September 9th, 2020 • California
This Agreement is made and entered into by and between the City of Milpitas, California, a California municipal corporation (“Licensor” or “City”) and GTE Mobilnet of California Limited Partnership, d/b/a Verizon Wireless (“Licensee”). Licensor and Licensee may be referred to herein individually as a “Party” or collectively as the “Parties.”
NON-EXCLUSIVE LICENSE TO USE MUSICAL WORKSNon-Exclusive License Agreement • December 27th, 2022
The company under the corporate name “ORFIUM GREECE SINGLE MEMBER SOCIÉTÉ ANONYME” and the distinctive title “ORFIUM GREECE SINGLE MEMBER S.A.”, which is seated in Athens, Attica, at 103 Kallirois Ave., Vat. Reg. No. 801380551, ............., ……… Tax Office, General Electronic Commercial Registry (G.E.MI.) Number……………………………, legally represented by ,
Non-exclusive license to use Building Detection and ClassificationNon-Exclusive License Agreement • July 30th, 2024
By streaming and/or manipulating and/or using the PRODUCT, the LICENSEE signifies that it unconditionally accepts all the terms and conditions of the present licence agreement (hereinafter referred to as the “LICENCE”). The acceptance by the LICENSEE of this LICENCE is the condition upon which Aventior makes the PRODUCT available to the LICENSEE. The LICENSEE of the PRODUCT shall guarantee that the PRODUCT and any copy are used in strict compliance with the terms hereof.
NON-EXCLUSIVE LICENSE AGREEMENT FOR [ TITLE ]*Non-Exclusive License Agreement • March 13th, 2024
This non-exclusive license agreement (“AGREEMENT”) is effective on [DATE] (“Effective Date”), and is by and between REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California corporation, whose legal address is 1111 Franklin Street, 12th Floor, Oakland, California 94607- 5200, acting through its Office of Technology Licensing, at the University of California, Berkeley, 2150 Shattuck Avenue, Suite 408, Berkeley, CA 94704-1362 ("REGENTS") and [LICENSEE name], a [State of incorporation] corporation having a principal place of business at [LICENSEE address] ("LICENSEE"). The parties agree as follows:
Non-Exclusive License AgreementNon-Exclusive License Agreement • March 8th, 2024
to be published by ASERS Publishing (hereinafter ‘Licensor’ or ‘Publisher’) in: Journal of Research in Educational Sciences, ISSN: 2068 – 8407, Journal DOI: https://doi.org/10.14505/jres, website: http://journals.aserspublishing.eu/jres e-mail: jres@aserspublishing.eu.
EX-10.14 17 d447521dex1014.htm EX-10.14 SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE CONFIDENTIAL TREATMENT FOR THOSE TERMS HAS BEEN REQUESTED. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION,...Non-Exclusive License Agreement • May 5th, 2020
THIS NON-EXCLUSIVE LICENSE AGREEMENT (the “Agreement”), effective as of October 31, 2013 (the “Effective Date”), is entered into by and between BioWa, Inc., with a principal place of business at 9420 Athena Circle, La Jolla, California 92037 USA (“BioWa”), Lonza Sales AG a Swiss corporation, with a principal place of business at Munchensteinerstrasse 38, Basel, CH-4002 Switzerland (“Lonza”) (together “the Licensor”) and Allakos, Inc. with its principal place of business located at 75 Shoreway Road, Suite A San Carlos CA 94070 (“Licensee”). Lonza, BioWa, Licensor or Licensee may hereafter be referred to as a “Party” and collectively as the “Parties.”
NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNS HOPKINS UNIVERSITY CLINICAL MICRO SENSORS DBA OSMETECH MOLECULAR DIAGNOSTICS JHU Ref: 9328Non-Exclusive License Agreement • May 25th, 2010 • GenMark Diagnostics, Inc. • Surgical & medical instruments & apparatus • Maryland
This Non-exclusive License Agreement (hereinafter referred to as the “Agreement”) is by and between The Johns Hopkins University (hereinafter referred to as “JHU”), a corporation of the State of Maryland, having a principal place of business at 3400 N. Charles Street, Baltimore, Maryland 21218-2695, and Clinical Micro Sensors (hereinafter referred to as “Company”), Doing Business As Osmetech Molecular Diagnostics, a corporation incorporated in the State of California, located at 757 South Raymond Avenue., Pasadena, CA 91105.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Michigan
This Agreement is entered into as of , 201_ (“Effective Date”), by and between Wayne State University, a non-profit Michigan educational institution (“WSU”) and
CONFIDENTIAL TREATMENT REQUESTED NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • January 15th, 2016 • AveXis, Inc. • Biological products, (no disgnostic substances) • New York
This Non-Exclusive License Agreement (this “Agreement”) is made and entered into as of this 29th day of May, 2015 (the “Effective Date”), by and between ASKLEPIOS BIOPHARMACEUTICAL, INC., a North Carolina corporation with an address at 45 North Chatham Parkway, Chapel Hill, NC 27517 (“AskBio”), and AVEXIS, INC., a Delaware corporation with an address at 4925 Greenville Avenue, Suite 604, Dallas, Texas 75206 (“AveXis”). AskBio and AveXis may be referred to herein individually as a “Party” and collectively as the “Parties.”
Non-Exclusive) Agreement (100,000) DownloadsNon-Exclusive License Agreement • November 27th, 2022
The terms and conditions of the (“Customer” or “Licensee”) use of the (“Song Composer” or “Licensor”) Track, as well as the rights granted in it, are outlined in this (Non-Exclusive) License Agreement, which was made between the (“Song Composer” or “Licensor”) and (“Customer” or “Licensee”) on the date of purchase in exchange for the Licensee's payment of the listed Product Price. This Agreement is issued solely in connection with and for Licensee's use of the Track pursuant and subject to all terms and conditions set forth herein.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • January 31st, 2014 • uniQure B.V. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”), effective as of September 3, 2010 (the “Effective Date”), is by and between Asklêpios Biopharmaceutical, Inc., an entity organized and existing under the laws of the State of North Carolina, with its registered office located at 45 N. Chatham Parkway, Chapel Hill, NC 27517 (the “AskBio”), and Amsterdam Molecular Therapeutics (AMI) B.V., with offices located at Meibergdreef 61, 1100 DA Amsterdam, The Netherlands (“AMT”). AMT and AskBio may be hereinafter referred to individually as “Party” and jointly as “Parties”.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • December 31st, 2021
This Non-Exclusive License Agreement (“Agreement”) is made between the Visual Information Processing and Learning (VIPL) group of Institute of Computing Technology (ICT) Chinese Academy of Sciences (CAS) and _
EAST SILVER NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • February 18th, 2021
EAST SILVER, a project duly organized and validly existing under the laws of the Czech Republic, having the address of Stepanska 14, 110 00 Praha 1, Czech Republic (hereinafter “LICENSEE”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This Non-Exclusive License Agreement (“Agreement”) is made and entered into this 3rd day of February, 2004 (the “Effective Date”), by and between Advanced Cell Technology, Inc., a Delaware corporation with offices located at One Innovation Drive, Worcester, Massachusetts 01605 (“ACT”), and One Degree Genetics LLC, a Delaware limited liability company with offices located at 18 Plimpton Road, Westerly, R.I. 02891 (“LICENSEE”) (ACT and LICENSEE sometimes hereinafter referred to as the “parties”).
NON-EXCLUSIVE LICENSE AGREEMENT Regents of the University of MinnesotaNon-Exclusive License Agreement • February 12th, 2024
THIS NON-EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made as of the Effective Date by and between Regents of the University of Minnesota, a constitutional corporation under the laws of the state of Minnesota, having a place of business at 200 Oak Street, SE, Suite 280, Minneapolis, Minnesota 55455 (the “University”), and the Licensee identified below.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Massachusetts
University of Massachusetts ("University"), a public institution of higher education of the Commonwealth of Massachusetts as represented by its medical school at the Worcester campus with an address at 222 Maple Avenue, Higgins Building, Shrewsbury, MA 01545, U.S.A., and
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • October 7th, 2019 • California
CAREFULLY READ THE FOLLOWING LICENCE AGREEMENT CAREFULLY! IT CONTAINS VERY IMPORTANT INFORMATION ABOUT YOUR RIGHTS AND OBLIGATIONS, AS WELL AS LIMITATIONS AND EXCLUSIONS THAT MAY APPLY TO YOU. BY CLICKING ON THE “AGREE” BOX, YOU ARE CONSENTING TO BE BOUND BY AND ARE BECOMING A PARTY TO THIS AGREEMENT. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, DO NOT CLICK THE AGREE BUTTON AND LEAVE THE WEBSITE.
NON-EXCLUSIVE LICENSE AGREEMENT between Heart Test Laboratories, Inc. and Icahn School of Medicine at Mount SinaiNon-Exclusive License Agreement • September 21st, 2023 • Heart Test Laboratories, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This Non-Exclusive License Agreement (this “Agreement”) is by and between Icahn School of Medicine at Mount Sinai, a New York not-for-profit education corporation, with a principal place of business at One Gustave L. Levy Place, New York, NY 10029 (“Mount Sinai”) and Heart Test Laboratories, Inc. d/b/a HeartSciences a Texas corporation, with a principal place of business at 550 Reserve Street, Suite 360, Southlake, TX 76092 (referred to herein as (“Licensee”). This Agreement shall become effective upon the Closing (the “Effective Date”), which shall be deemed the Closing Date. Mount Sinai and Licensee are each referred to herein as a “Party” and collectively as the “Parties.” Terms not defined herein shall have the meaning ascribed to them in the Securities Purchase Agreement between the Parties, executed contemporaneously herewith (the “SPA”) and annexed hereto as Exhibit A.
CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION NON-EXCLUSIVE LICENSE AGREEMENT by and between MERCK SHARP & DOHME CORP. and P53 INC.Non-Exclusive License Agreement • April 23rd, 2015 • MultiVir Inc. • Pharmaceutical preparations • New Jersey
This Non-Exclusive License Agreement (this “Agreement”), effective as of the date of last signature hereto (the “Effective Date”), is entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey, having a place of business at One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey 08889 (“Merck”) and P53 INC., a corporation organized and existing under the laws of Delaware, having a place of business at 2000 Edwards Street, Houston, TX 77007 (“P53”).
Non-exclusive License AgreementNon-Exclusive License Agreement • July 14th, 2023 • Northann Corp. • Plastics products, nec • Delaware
This License Agreement (this “Agreement”) is entered into as of this 10th day of September, 2021 (the “Effective Date”), by and between Interglobal Forest LLC , an existing under the laws of United States, having a place of business at (“Licensee”) and Benchwick Construction
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • January 10th, 2008 • Rxi Pharmaceuticals Corp • Pharmaceutical preparations • Massachusetts
This Agreement, effective as of January 10, 2007 (the “Effective Date”), is between the University of Massachusetts (“University”), a public institution of higher education of the Commonwealth of Massachusetts as represented by its Worcester campus, and, RXi Pharmaceuticals Corporation (“Company”), a Delaware corporation.
NON-EXCLUSIVE LICENSE FOR USE OF SCHOOL WORDMARKS AND LOGOSNon-Exclusive License Agreement • August 14th, 2020 • Texas
THIS LICENSE AGREEMENT (hereinafter "Agreement") is entered into by and between Allen Independent School District, an independent school district organized under the laws of the State of Texas, having a principal place of business in Allen, Texas (hereinafter referred to as ("Allen") and
Non-Exclusive License Agreement between Enteris Biopharma, Inc. and CARA THERAPEUTICS, INC. Dated as of August 20, 2019Non-Exclusive License Agreement • November 14th, 2019 • SWK Holdings Corp • Miscellaneous business credit institution • New York
This NON-EXCLUSIVE License AGREEMENT (“Agreement”) is made August 20, 2019 (the “Effective Date”) by and between CARA THERAPEUTICS, INC., incorporated and registered in the State of Delaware and having offices at 4 Stamford Plaza, 107 Elm Street, 9th Floor, Stamford, CT 06902, USA (hereinafter referred to as “Cara”), and Enteris Biopharma, Inc., incorporated and registered in the State of Delaware and having offices at 83 Fulton St., Boonton, NJ 07005, USA (hereinafter referred to as “Enteris”). Each of Enteris and Cara is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
CONFIDENTIAL Non-Exclusive License AgreementNon-Exclusive License Agreement • February 14th, 2007 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This agreement (the “Agreement”) is by and between Max-Planck-Innovation GmbH, a German corporation having a principal place of business at Marstallstr. 8, 80539 Muenchen, Germany (“MI”), and Rosetta Genomics Ltd., an Israeli corporation having a principal place of business at 10 Plaut Street, Science Park, Rehovot 76706, Israel (“COMPANY”). This Agreement will become effective on December 22, 2006 (the “Effective Date”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • August 17th, 2015 • Syncardia Systems Inc • Surgical & medical instruments & apparatus • Minnesota
This Non-Exclusive License Agreement (“Agreement”) is effective this 27th day of July, 2013 (“Effective Date”), between Medtronic Inc., having an address at 8200 Coral Sea Street N.E., Moundsview, MN 55112 (“Medtronic”), and SynCardia Systems, Inc., having an address at 1992 Silverlake Road, Tucson, AZ 85713 (“SynCardia”). Each of Medtronic and SynCardia is referred to herein individually as a “Party” and together as the “Parties.”
Non-Exclusive Licence AgreementNon-Exclusive License Agreement • April 29th, 2011
By agreeing with and accepting this licence, I (the author, co-author, nominated agent or copyright owner) grant to Cadmus, the digital institutional repository of the European University Institute (EUI), or to any other digital repository authorized for use by the EUI, the non-exclusive right to reproduce, render (as defined below), and/or distribute my submission, referred to as the ‘Work’, worldwide in electronic format and in any medium for the lifetime of the repository.
EX-10.45 9 dex1045.htm NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN SEATTLE GENETICS, INC. AND ICOS CORP. NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Washington
This Non-exclusive License Agreement (the “Agreement”), effective as of October 16th, 2000 (The “Effective Date”), is entered into by and between ICOS Corporation, a Delaware corporation having offices at 22021 20th Avenue SE, Bothell, WA 98021, U.S.A., (“ICOS”), and Seattle Genetics, Inc., a Delaware corporation having offices at 22215 26th Avenue S.E., Suite 300, Bothell, WA 98021 (“LICENSEE”). All references to LICENSEE in this Agreement shall include its Affiliates (as such term is defined below).
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. NON- EXCLUSIVE LICENSE...Non-Exclusive License Agreement • May 28th, 2021 • Verve Therapeutics, Inc. • Pharmaceutical preparations • New York
This Non-Exclusive License Agreement (“License Agreement”), dated as of October 14, 2020 (the “License Agreement Effective Date”), is made by and between Acuitas Therapeutics, Inc., a British Columbia corporation (“Acuitas”), and Verve Therapeutics, Inc., a Delaware corporation (“Verve”). Each of Acuitas and Verve may be referred to herein as a “Party” or together as the “Parties.”
